Literature DB >> 19837082

Calcitriol upregulates open chromatin and elongation markers at functional vitamin D response elements in the distal part of the 5-lipoxygenase gene.

Kirsten L Stoffers1, Bernd L Sorg, Sabine Seuter, Oliver Rau, Olof Rådmark, Dieter Steinhilber.   

Abstract

5-Lipoxygenase (5-LO) gene expression is strongly upregulated during induction of myeloid cell differentiation by 1alpha,25-dihydroxyvitamin D(3) (calcitriol) and transforming growth factor-beta (TGFbeta) in a promoter-independent manner. In an activity-guided approach using reporter gene assays where the distal part of the 5-LO gene was included in the reporter gene plasmid, we localized vitamin D response elements (VDREs) within exon 10, exon 12, and intron M. We found that these newly identified VDRE sites are bound by vitamin D receptor both in vitro by gel-shift analysis and in vivo by chromatin immunoprecipitation assays. In reporter gene assays, the distal part of the 5-LO gene has promoter-like activity that is inducible by calcitriol in a vitamin D receptor-dependent manner. The vitamin D effects were attenuated when the VDREs in exon 10, exon 12, and intron M were deleted or mutated. When we analyzed the effects of calcitriol plus TGFbeta on chromatin modifications at exon 10, exon 12, and intron M of the 5-LO gene in Mono Mac 6 cells by chromatin immunoprecipitation analysis, we found an increase in histone H4 K20 monomethylation and a prominent presence of histone H3 K36 trimethylation. Combined treatment with calcitriol and TGFbeta also increased histone H4 acetylation, a marker for open chromatin, and the elongation form of RNA polymerase II at these sites, whereas the transcription initiation marker histone H3 K4 trimethylation was almost undetectable. The data suggest that calcitriol induces chromatin opening and transcript elongation via VDREs located at the 3'-end of the 5-LO gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837082     DOI: 10.1016/j.jmb.2009.10.022

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Calcitriol induces estrogen receptor α expression through direct transcriptional regulation and epigenetic modifications in estrogen receptor-negative breast cancer cells.

Authors:  Nancy Santos-Martínez; Lorenza Díaz; Victor M Ortiz-Ortega; David Ordaz-Rosado; Heriberto Prado-Garcia; Euclides Avila; Fernando Larrea; Rocío García-Becerra
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

2.  Post-transcriptional regulation of 5-lipoxygenase mRNA expression via alternative splicing and nonsense-mediated mRNA decay.

Authors:  Meike J Ochs; Bernd L Sorg; Laura Pufahl; Manuel Grez; Beatrix Suess; Dieter Steinhilber
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 3.  Impact of vitamin D on immune function: lessons learned from genome-wide analysis.

Authors:  Rene F Chun; Philip T Liu; Robert L Modlin; John S Adams; Martin Hewison
Journal:  Front Physiol       Date:  2014-04-21       Impact factor: 4.566

4.  Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.

Authors:  Laura Pufahl; Careen Katryniok; Nicole Schnur; Bernd L Sorg; Julia Metzner; Manuel Grez; Dieter Steinhilber
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

5.  Inhibition of class I HDACs abrogates the dominant effect of MLL-AF4 by activation of wild-type MLL.

Authors:  K Ahmad; C Katryniok; B Scholz; J Merkens; D Löscher; R Marschalek; D Steinhilber
Journal:  Oncogenesis       Date:  2014-11-17       Impact factor: 7.485

Review 6.  Vitamin D in inflammatory diseases.

Authors:  Thea K Wöbke; Bernd L Sorg; Dieter Steinhilber
Journal:  Front Physiol       Date:  2014-07-02       Impact factor: 4.566

7.  AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3.

Authors:  Khalil Ahmad; Bastian Scholz; Ricardo Capelo; Ilona Schweighöfer; Astrid Stefanie Kahnt; Rolf Marschalek; Dieter Steinhilber
Journal:  Oncotarget       Date:  2015-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.